[속보] Pfizer Corona Vaccine Serious Side Effects, Anaphylaxis General Paralysis, New York Stock Market Dow Nasdaq Stock Index Futures Emergency

Pfizer’s coronavirus vaccine in the U.S. had a serious side effect, causing an emergency. Anaphylaxis shock occurred after vaccinating Pfizer. Dow and Nasdaq stock index futures have been staggering on the New York Stock Market after news of the vaccine side effects.

According to the New York Stock Exchange on the 24th, the New York City Health Authority’s Ministry of Health and Mental Hygiene said, “A medical practitioner showed a’anaphylaxis’ reaction after vaccinating Pfizer.” It is the first serious adverse event reported since the initiation of Pfizer’s COVID-19 vaccination in the United States. Anaphylaxis is a rapid systemic reaction caused by an antigen-antibody immune response. Difficulty breathing, decreased blood pressure, and systemic shock can be accompanied. Earlier, the Centers for Disease Control and Prevention (CDC) recommended that if you get the Corona 19 vaccine and you have serious allergic side effects, you should not take the second dose. In the UK, where the Pfizer vaccination was started before the US, two serious allergic side effects, anaphylaxis, were reported on the 8th.

Meanwhile, Prime Minister Jeong Sye-gyun announced that it has signed a contract with Janssen (Johnson & Johnson) on the same day for 6 million Corona 19 vaccines. Janssen’s contract size is 6 million, an increase from the originally planned 2 million. Janssen’s COVID-19 vaccine, a pharmaceutical subsidiary of Johnson & Johnson, has the advantage that storage and distribution conditions are not demanding, similar to AstraZeneca products. Janssen vaccine can be stored at 2-8℃ for 6 months. Janssen’s Corona 19 vaccine is the only product that is given once in a pandemic situation among the four vaccines that the Korean government has announced to bring. Johnson & Johnson is undergoing phase 3 clinical trials in which 60,000 people around the world are tested for efficacy after one dose from September this year. It is expected to end in the first quarter of next year. In October, during a clinical trial in Brazil, an unknown disease occurred in one patient who received the vaccine, and the clinical trial was stopped at an early stage.

Prime Minister Jeong Sye-gyun announced on the 24th at the Corona 19 critical script meeting presided over at the government’s Seoul government building that “Pfizer vaccine contracted for 10 million people, and will be available from the third quarter of next year.” The COVID-19 vaccine, jointly developed by Pfizer and Bioentech, Germany, received attention as it showed a preventive effect of about 95% as a result of phase 3 clinical trials. Pfizer’s vaccine is a’nucleic acid vaccine’, a principle that elicits immunity by making the appearance of existing human cells similar to the actual Corona 19 virus. Pfizer vaccine should be kept in a cryogenic’cold chain’ (refrigerated distribution) at -80 to -60°C for 6 months storage. When stored at 2-8℃, which is a general refrigerated distribution temperature, 5 days is the limit.

Daeho Kim, Director of Global Economic Research Institute [email protected]